NASDAQ: ALZN
Alzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?

Insider buying vs selling

Have Alzamend Neuro Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Milton C. Ault IiiDirector2026-04-14108,388$1.01
$108.93kBuy
Milton C. Ault IiiDirector2025-12-231,851$2.07
$3.83kSell
William B. HorneDirector2025-12-193,333$2.12
$7.06kSell
Lynne Fahey McGrathDirector2025-10-2330$2.29
$68.70Sell
Milton C. Ault IiiDirector2025-10-0920,397$2.32
$47.38kSell
Milton C. Ault IiiDirector2025-10-08101,394$2.44
$247.20kSell
Milton C. Ault IiiDirector2025-10-0861,743$2.32
$143.24kBuy
Milton C. Ault IiiDirector2025-10-0757,379$2.49
$142.93kSell
Milton C. Ault IiiDirector2025-10-07100,000$2.32
$232.00kBuy
Milton C. Ault IiiDirector2025-10-0682,033$2.45
$201.31kSell

1 of 3

ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALZN insiders and whales buy or sell their stock.

ALZN Shareholders

What type of owners hold Alzamend Neuro Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Milton C. Ault Iii732.82%35,113,460$50.21MInsider
Jeffrey Oram2.09%100,000$143.00kInsider
Andrew H. Woo2.09%100,000$143.00kInsider
Mark Gustafson1.25%60,000$85.80kInsider
Geode Capital Management LLC0.95%45,680$65.32kInstitution
Stephan Jackman0.95%45,500$65.07kInsider
Vanguard Fiduciary Trust Co0.44%21,020$30.06kInstitution
Morgan Stanley0.38%18,000$25.74kInstitution
Clearstead Advisors LLC0.21%10,000$14.30kInstitution
Tower Research Capital LLC Trc0.13%6,184$8.84kInstitution

1 of 2

ALZN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALZN0.32%99.68%Net Buying
XBIO3.90%96.10%
IMNN5.39%94.61%Net BuyingNet Buying
KAPA2.81%35.51%
EVGN5.10%0.84%

Alzamend Neuro Stock Ownership FAQ

Who owns Alzamend Neuro?

Alzamend Neuro (NASDAQ: ALZN) is owned by 2.41% institutional shareholders, 739.32% Alzamend Neuro insiders, and 0.00% retail investors. Milton C. Ault Iii is the largest individual Alzamend Neuro shareholder, owning 35.11M shares representing 732.82% of the company. Milton C. Ault Iii's Alzamend Neuro shares are currently valued at $50.21M.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.